A recent article in the Puget Sound Business Journal details the critical role hospitals are playing in helping King County’s uninsured enroll in health care coverage through the state’s new Health Benefit Exchange (Exchange). In the piece, Swedish’s Tom Gibbon, Medicaid Expansion/Exchange Initiative Leader, highlights how Swedish is helping patients by:
Swedish Neuroscience Institute Seeks Participants for Trial of an Investigational Technology to Treat Essential Tremor
One of only four sites in U.S. to treat neurological disorder
SEATTLE, Sept. 26, 2013 – Swedish Neuroscience Institute (SNI) is looking for patients willing to participate in a study of an investigational technology to treat essential tremor, a common neurological disorder, with sound rather than surgery.
An estimated 10 million people in the U.S have essential tremor (ET), which causes a rhythmic shaking or trembling of hands and arms but can also affect the head, legs and other parts of the body. It affects one out of every 25 adults over 40 and can be confused with but is different from better-known Parkinson’s disease, which is actually much less prevalent. ET produces disabilities that hamper basic daily activities and worsens over time, with severely affected patients unable to feed or care for themselves.
Dr. Ryder Gwinn, the Principle Investigator for the study at SNI who has utilized other treatments for patients with essential tremor, said focused ultrasound could be an option for many of these patients. For example, medication has been shown to be ineffective for up to half of all ET patients.
Two of the three North Sound public district hospitals, who formed a consortium called the Interlocals, announced a decision today to explore a formal affiliation with PeaceHealth and UW Medicine. Skagit Regional Health and Cascade Valley Hospital will pursue the affiliation. Island Hospital announced it will not pursue an affiliation at this time.
SEATTLE, August 16, 2013 - Now in its 13th year, Seattle magazine recently published the results of their annual 'Top Doctors' survey in the July issue. As in past years, dozens of Swedish-affiliated (or credentialed) physicians were recognized in the popular issue due to being nominated by their peers.
Additionally, Seattle Metropolitan magazine published the results of its 'Top Doctors' survey in the August issue, in which dozens of Swedish-affiliated (or credentialed) physicians were also featured
SEATTLE — Aug. 15, 2013 — Swedish, the largest nonprofit healthcare provider in the greater Seattle area, announced today that Dr. Charles S. Cobbs will lead The Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment (Ivy Center) at the Swedish Neuroscience Institute as its new director. The Ivy Center was founded on a mission to combine research science with medical treatments to advance the field of brain cancer and to give new hope to each person diagnosed with the disease.
Dr. Cobbs is a neurosurgeon and internationally recognized expert in brain cancer treatment and research. He was personally selected for this role by Dr. Greg Foltz, the inaugural director and founder of the Ivy Center, who passed away on June 27, 2013 from pancreatic cancer.
SEATTLE, Wash., August 8, 2013 — The American Hospital Association (AHA) today named John Vassall, M.D., to its Board of Trustees. The Board of Trustees makes policy for the AHA and has authority over its governance and management. Dr. Vassall, chief medical officer at Swedish Medical Center, joins seven other new board members who will begin their three-year terms on Jan. 1, 2014.
The AHA is a national organization representing nearly 5,000 hospitals, health care networks, and other care providers. Through its advocacy activities, AHA ensures that members' perspectives and needs are heard and addressed in national health policy development, legislative and regulatory debates, and judicial matters.
SEATTLE — August 12, 2013 — More than 3,500 enthusiastic patients, survivors and supporters gathered in Seattle last month to participate in the 19th annual Swedish presents SummeRun & Walk for ovarian cancer. Thanks to energized and proactive participants, this year’s event raised more than $558,000 in support of ovarian cancer research.
The SummeRun & Walk celebrates and remembers the lives of those who have been impacted by ovarian cancer. It is the Northwest’s largest community event to raise awareness and vital funds for ovarian cancer. Since its inception, the SummeRun has raised more than $6 million for medical research into the treatment, early detection, and prevention of this disease.